Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma

Although C̄l-inhibitor (C̄l-INH) and α(2)-macroglobulin (α(2)M) have been reported as the major inhibitors of plasma kallikrein in normal plasma, there is little quantitative support for this conclusion. Thus, we studied the inactivation of purified kallikrein in normal plasma, as well as in plasma...

Description complète

Détails bibliographiques

Publié dans:	J Clin Invest
Auteurs principaux:	Schapira, Marc, Scott, Cheryl F., Colman, Robert W.
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Clinical Investigation 1982
Sujets:	Articles
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC370996/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6173399/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110470
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!